nat10 overexpressing plasmids (Shanghai GenePharma)
90
Structured Review
Shanghai GenePharma
nat10 overexpressing plasmids
Nat10 Overexpressing Plasmids, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nat10+overexpression+plasmid/nat10+overexpression+plasmid/pm40368770-69-13-25
Average 90 stars, based on 1 article reviews
Nat10 Overexpressing Plasmids, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nat10+overexpression+plasmid/nat10+overexpression+plasmid/pm40368770-69-13-25
Average 90 stars, based on 1 article reviews
nat10 overexpressing plasmids - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Small Interfering RNA:Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44 / PI3K / AKT Pathway Article Snippet: In addition, DDP‐resistant NSCLC cells were cultured in a medium added with 1 μg/mL DDP (Abace Biology, Beijing, China) to maintain their resistance. .. The small interfering RNA targeting NAT10 (si‐NAT10), Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non-Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway. Article Snippet: In addition, DDP- resistant NSCLC cells were cultured in a medium added with 1 μg/mL DDP (Abace Biology, Beijing, China) to maintain their resistance. .. The small interfering RNA targeting NAT10 (si- NAT10), Over Expression:Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44 / PI3K / AKT Pathway Article Snippet: In addition, DDP‐resistant NSCLC cells were cultured in a medium added with 1 μg/mL DDP (Abace Biology, Beijing, China) to maintain their resistance. .. The small interfering RNA targeting NAT10 (si‐NAT10), Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non-Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway. Article Snippet: In addition, DDP- resistant NSCLC cells were cultured in a medium added with 1 μg/mL DDP (Abace Biology, Beijing, China) to maintain their resistance. .. The small interfering RNA targeting NAT10 (si- NAT10), Plasmid Preparation:Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44 / PI3K / AKT Pathway Article Snippet: In addition, DDP‐resistant NSCLC cells were cultured in a medium added with 1 μg/mL DDP (Abace Biology, Beijing, China) to maintain their resistance. .. The small interfering RNA targeting NAT10 (si‐NAT10), Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non-Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway. Article Snippet: In addition, DDP- resistant NSCLC cells were cultured in a medium added with 1 μg/mL DDP (Abace Biology, Beijing, China) to maintain their resistance. .. The small interfering RNA targeting NAT10 (si- NAT10), |